Minimizing femoral artery access complications during percutaneous coronary intervention: A comprehensive review

Catheterization and Cardiovascular Interventions

Volumn 84, Issue 1, 2014, Pages 62-69

  Lee, Michael S ^a   Applegate, Bob ^b   Rao, Sunil V ^c   Kirtane, Ajay J ^d   Seto, Arnold ^e   Stone, Gregg W ^d  

^a UCLA MEDICAL CENTER   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^e VA LONG BEACH HEALTHCARE SYSTEM   (United States)

Author keywords

bleeding complications; PCI; vascular complications

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG;

BLEEDING TENDENCY; DEVICE REMOVAL; DRUG CONTRAINDICATION; FEMORAL ANGIOGRAPHY; FEMORAL ARTERY; FLUOROSCOPY; HUMAN; HYPERTENSION; LENGTH OF STAY; PERCUTANEOUS CORONARY INTERVENTION; PEROPERATIVE COMPLICATION; PUNCH BIOPSY; REVIEW; RISK FACTOR; RISK REDUCTION; SURGICAL RISK; TREATMENT PLANNING; ULTRASOUND; VASCULAR ACCESS; VASCULAR CLOSURE DEVICE; VASCULAR DISEASE; ADVERSE EFFECTS; COMPUTER ASSISTED SURGERY; CORONARY ARTERY DISEASE; POSTOPERATIVE HEMORRHAGE; PROCEDURES; PUNCTURE;

CORONARY ARTERY DISEASE; FEMORAL ARTERY; HUMANS; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE HEMORRHAGE; PUNCTURES; RISK FACTORS; SURGERY, COMPUTER-ASSISTED;

EID: 84903528199     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25435     Document Type: Review

References (46)

1. Rao SV, Jollis JG, Harrington RA, Granger CB, Newby LK, Armstrong PW, Moliterno DJ, Lindblad L, Pieper K, Topol EJ, Stamler JS, Califf RM,. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004; 292: 1555-1562.
2. Manoukian S, Feit F, Mehran R, Voeltz MD, Ebrahimi R, Hamon M, Dangas GD, Lincoff M, White HD, Moses JW, et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY trial. J Am Coll Cardiol 2007; 49: 1362-1368.
3. Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S,. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 2006; 114: 774-782.
4. Rapoport S, Sniderman KW, Morse SS, Proto MH, Ross GR,. Pseudoaneurysm: a complication of faulty technique in femoral arterial puncture. Radiology 1985; 154: 529-530.
5. Garrett PD, Eckart RE, Bauch TD, Thompson CM, Stajduhar KC,. Fluoroscopic localization of the femoral head as a landmark for common femoral artery cannulation. Catheter Cardiovasc Interv 2005; 65: 205-207.
6. Schnyder G, Sawhney N, Whisenant B, Tsimikas S, Turi ZG,. Common femoral artery anatomy is influenced by demographics and comorbidities: implications for cardiac and peripheral invasive studies. Catheter Cardiovasc Interv 2001; 53: 289-295.
7. Fitts J, Ver LP, Hofmaster P, Malenka D,. Fluoroscopy-guided femoral artery puncture reduces the risk of PCI-related vascular complications. J Interv Cardiol. 2008; 21: 273-278.
8. Turi ZG,. Fluoroscopy guided vascular access: asking the right question, but getting the wrong answer? Catheter Cardiovasc Interv 2009: 74: 540-542.
9. Baim SD,. Percutaneous approach, including trans-septal and apical puncture., In,:, Baim SD, Grossman, W, editors,. Grossman's Cardiac Catheterization, Angiography, and Intervention, 6th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2000. pp 69-100.
10. Ahmed B, Piper WD, Malenka D, et al. Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry. Circ Cardiovasc Interv 2009; 2: 423-429.
11. Abu-Fadel MS, Sparling JM, Zacharias SJ, et al. Fluoroscopy vs. traditional guided femoral arterial access and the use of closure devices: a randomized controlled trial. Catheter Cardiovasc Interv 2009; 74: 533-539.
12. Jacobi J, Schussler JM, Johnson KB,. Routine femoral head fluoroscopy to reduce complications in coronary catheterization. Proc (Bayl Univ Med Cent) 2009; 22: 7-8.
13. Huggins CE, Gillespie MJ, Tan WA, et al. A prospective randomized clinical trial of the use of fluoroscopy in obtaining femoral arterial access. J Invasive Cardiol 2009; 21: 105-109.
14. Seto AH, Abu-Fadel MS, Sparling JM, et al. Real-time ultrasound guidance facilitates femoral arterial access and reduces vascular complications: FAUST (Femoral Arterial Access With Ultrasound Trial). JACC Cardiovasc Interv 2010; 3: 751-758.
15. Ben-Dor I, Maluenda G, Mahmoudi M, Torguson R, Xue Z, Bernardo N, Lindsay J, Satler LF, Pichard AD, Waksman R,. A novel, minimally invasive access technique versus standard 18-gauge needle set for femoral access. Catheter Cardiovasc Interv 2012; 79: 1180-1185.
16. Trimarchi S, Smith DE, Share D, Jani SM, O'Donnell M, McNamara R, Riba A, Kline-Rogers E, Gurm HS, Moscucci M,; BMC2 Registry. Retroperitoneal hematoma after percutaneous coronary intervention: prevalence, risk factors, management, outcomes, and predictors of mortality: a report from the BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) registry. JACC Cardiovasc Interv 2010; 3: 845-850.
17. Sanborn TA, Ebrahimi R, Manoukian SV, McLaurin BT, Cox DA, Feit F, Hamon M, Mehran R, Stone GW,. Impact of femoral vascular closure devices and antithrombotic therapy on access site bleeding in acute coronary syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial. Circ Cardiovasc Interv 2010; 3: 57-62.
18. Sherev DA, Shaw RE, Brent BN,. Angiographic predictors of femoral access site complications: implication for planned percutaneous coronary intervention. Catheter Cardiovasc Interv 2005; 65: 196-202.
19. Turi ZG,. Ooze you lose: II, are we really getting better all the time? Catheter Cardiovasc Interv 2002; 57: 484-485.
20. Sittig KM, Rohr MS, McDonald JC,. Abdominal wall, umbilicus, peritonium, mesenteries, omentum, and retroperitonium. In:, Townsend CM, Buachamp RO, Evers BM, Mattay KL, editors. Sabistan Textbook of surgery. 16th ed. Philadelphia, PA: W.B. Saunders; 2001. pp 769-773.
21. Pitta SR, Prasad A, Kumar G, et al. Location of femoral artery access and correlation with vascular complications. Cathet Cardiovasc Interv 2011; 78: 294-299.
22. Tiroch KA, Arora N, Matheny M, Liu C, Lee TC, Resnic FS,. Risk predictors of retroperitoneal hemorrhage following percutaneous coronary intervention. Am J Cardiol 2008; 102: 1473-1476.
23. Patel MR, Jneid H, Derdeyn CP, Klein LW, Levine GN, Lookstein RA, White CJ, Yeghiazarians Y, Rosenfield K,; American Heart Association Diagnostic and Interventional Cardiac Catheterization Committee of the Council on Clinical Cardiology, Council on Cardiovascular Radiology and Intervention, Council on Peripheral Vascular Disease, Council on Cardiovascular Surgery and Anesthesia; Stroke Council. Arteriotomy closure devices for cardiovascular procedures: a scientific statement from the American Heart Association. Circulation 2010; 122: 1882-1893.
24. Alexander KP, Chen AY, Roe MT, et al. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. JAMA 2005; 294: 3108-3116.
25. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011; 124: 2574-609.
26. Brener SJ, Moliterno DJ, Lincoff AM, Steinhubl SR, Wolski KE, Topol EJ,. Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention. Circulation 2004; 110: 994-998.
27. Doyle BJ, Ting HH, Bell MR, Lennon RJ, Mathew V, Singh M, Holmes DR, Rihal CS,. Major femoral bleeding complications after percutaneous coronary intervention: Incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005. J Am Coll Cardiol Intv 2008; 1: 202-209.
28. Stabile E, Nammas W, Salemme L, et al. The CIAO (Coronary Interventions Antiplatelet-based Only) study: A randomized study comparing standard anticoagulation regimen to absence of anticoagulation for elective percutaneous coronary intervention. J Am Coll Cardiol 2008; 52: 1293-1298.
29. Godon P, Rioufol G, Finet G, et al. Efficacy and safety of low-dose heparin (30 IU/kg) during coronary angioplasty. Arch Mal Coeur Vaiss 2001; 94: 984-988.
30. Kastrati A, Mehilli J, Neumann FJ, Dotzer F, ten Berg J, Bollwein H, Graf I, Ibrahim M, Pache J, Seyfarth M, Schühlen H, Dirschinger J, Berger PB, Schömig A,; Intracoronary Stenting and Antithrombotic: Regimen Rapid Early Action for Coronary Treatment 2 (ISAR-REACT 2) Trial Investigators. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial. JAMA 2006; 295: 1531-1538.
31. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2012; 61: 1-26.
32. Blankenship JC, Balog C, Sapp SK, et al. Reduction in vascular access site bleeding in sequential abciximab coronary intervention trials. Catheter Cardiovasc Interv 2002; 57: 476-483.
33. Lincoff AM, Bittl JA, Harrington RA, Feit F, Kleiman NS, Jackman JD, Sarembock IJ, Cohen DJ, Spriggs D, Ebrahimi R, Keren G, Carr J, Cohen EA, Betriu A, Desmet W, Kereiakes DJ, Rutsch W, Wilcox RG, de Feyter PJ, Vahanian A, Topol EJ,; REPLACE-2 Investigators. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 2003; 289: 853-863.
34. Stone GW, McLaurin BT, Cox DA, et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med 2006; 355: 2203-2216.
35. Stone GW, Witzennbichler B, Guagliumi G, et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008; 358: 2218-2230.
36. Dehmer GJ, Weaver D, Roe MT, Milford-Beland S, Fitzgerald S, Hermann A, Messenger J, Moussa I, Garratt K, Rumsfeld J, Brindis RG,. A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: a report from the CathPCI Registry of the National Cardiovascular Data Registry, 2010 through June 2011. J Am Coll Cardiol 2012; 60: 2017-2031.
37. Applegate RJ, Sacrinty MT, Kutcher MA, Kahl FR, Gandhi SK, Santos RM, Little WC,. Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007. J Am Coll Cardiol Intv 2008; 1: 317-326.
38. Metz D, Meyer P, Touati C, et al. Comparison of 6F with 7F and 8F guiding catheters for elective coronary angioplasty: results of a prospective, multicenter, randomized trial. Am Heart J 1997; 134: 131-137.
39. Subherwal S, Bach RG, Chen AY, et al. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction. Circulation 2009; 119: 1873-1882.
40. Nikolsky E, Mehran R, Halkin A, Aymong ED, Mintz GS, Lasic Z, Negoita M, Fahy M, Krieger S, Moussa I, et al. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol 2004; 44: 1200-1209.
41. Vaitkus PT,. A meta-analysis of percutaneous vascular closure devices after diagnostic catheterization and percutaneous coronary intervention. J Invasive Cardiol 2004; 16: 243-246.
42. Arora N, Matheny ME, Sepke C, Resnic FS,. A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices. Am Heart J 2007; 153: 606-611.
43. Marso SP, Amin AP, House JA, Kennedy KF, Spertus JA, Rao SV, Cohen DJ, Messenger JC, Rumsfeld JS,; National Cardiovascular Data Registry. Association between bleeding events and in-hospital mortality after percutaneous coronary intervention. JAMA 2010; 303: 2156-2164.
44. Applegate RJ, Sacrinty M, Kutcher MA, et al. Vascular complications with newer generations of angioseal vascular closure devices. J Interv Cardiol 2006; 19: 67-74.
45. Balzer JO, Scheinert D, Diebold T, Haufe M, Vogl TJ, Biamino G,. Postinterventional transcutaneous suture of femoral artery access sites in patients with peripheral arterial occlusive disease: a study of 930 patients. Catheter Cardiovasc Interv 2001; 53: 174-181.
46. Bangalore S, Arora N, Resnic FS,. Vascular closure device failure: frequency and implications: a propensity-matched analysis. Circ Cardiovasc Interv 2009; 2: 549-556.